Scinai Immunotherapeutics Ltd. short interest was 69.31% of the float on September 15th, according to new data we received from Benzinga. Short interest totaled 451,633 shares, which was an increase of 5,382.31% from August 31st.
It is estimated that it would take 1.0 days for short sellers to buy back their shares, with current trading volumes.
Scinai Immunotherapeutics Ltd. Hedge Fund Activity
We have seen 8 institutional investors add shares of Scinai Immunotherapeutics Ltd. stock to their portfolio, and 3 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC added 35,942 shares (+inf%) to their portfolio in Q2 2026, for an estimated $9,078
- CITADEL ADVISORS LLC removed 34,562 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $19,700
- VIRTU FINANCIAL LLC added 19,485 shares (+inf%) to their portfolio in Q2 2026, for an estimated $4,921
- STONEX GROUP INC. added 13,092 shares (+inf%) to their portfolio in Q2 2026, for an estimated $3,307
- HRT FINANCIAL LP added 12,088 shares (+inf%) to their portfolio in Q2 2026, for an estimated $3,053
- CAPTRUST FINANCIAL ADVISORS added 12,035 shares (+inf%) to their portfolio in Q2 2026, for an estimated $3,040
- RHUMBLINE ADVISERS added 11,635 shares (+619.5%) to their portfolio in Q2 2026, for an estimated $2,939
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
